Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment.

MLA

Paciaroni, Katia, et al. “Severe Chronic Primary Neutropenia: Findings from a Patient Who Underwent Exstensive Evaluation Including Adenosine Deaminase 2 Gene Variant Assessment.” Leukemia & Lymphoma, vol. 64, no. 14, Dec. 2023, pp. 2343–46. EBSCOhost, https://doi.org/10.1080/10428194.2023.2255912.

APA

Paciaroni, K., Sangiorgi, E., Pulvirenti, F., Villiva, N., Andrizzi, C., Campagna, S., Tordi, A., Celesti, F., Manna, R., Gurrieri, F., Licci, S., & di Toritto, T. C. (2023). Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment. Leukemia & Lymphoma, 64(14), 2343–2346. https://doi.org/10.1080/10428194.2023.2255912

Chicago

Paciaroni, Katia, Eugenio Sangiorgi, Federica Pulvirenti, Nicoletta Villiva, Cristina Andrizzi, Selenia Campagna, Attilio Tordi, et al. 2023. “Severe Chronic Primary Neutropenia: Findings from a Patient Who Underwent Exstensive Evaluation Including Adenosine Deaminase 2 Gene Variant Assessment.” Leukemia & Lymphoma 64 (14): 2343–46. doi:10.1080/10428194.2023.2255912.